Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Praneeth R. Sudalagunta"'
Autor:
Ryan T. Bishop, Anna K. Miller, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S. Frieling, Mostafa M. Nasr, Karl J. Nyman, Praneeth R. Sudalagunta, Rafael R. Canevarolo, Ariosto Siqueira Silva, Kenneth H. Shain, Conor C. Lynch, David Basanta
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Multiple myeloma (MM) is an osteolytic malignancy that is incurable due to the emergence of treatment resistant disease. Defining how, when and where myeloma cell intrinsic and extrinsic bone microenvironmental mechanisms cause relapse is ch
Externí odkaz:
https://doaj.org/article/6a891d57aa954ccea72f58bdbad908a5
Autor:
Marilena Tauro, Tao Li, Mark Meads, Praneeth R. Sudalagunta, Raghunandan R. Alugubelli, Nicholas J. Lawrence, Ernst Schonbrunn, Harshani Lawrence, Kenneth H. Shain, Conor C. Lynch
Publikováno v:
Cancer Research. 83:452-452
Multiple myeloma (MM) is an incurable disease. Classical chemotherapeutics including bortezomib, melphalan, lenalidomide and thalidomide have greatly enhanced survival times. Unfortunately, patients typically relapse and become refractory with an ave
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a429f9809fbcc4c4dbcf828c80bf080
https://doi.org/10.1158/1538-7445.am2023-452
https://doi.org/10.1158/1538-7445.am2023-452